- Home
- ABEO vs LNZA Comparison
ABEO vs LNZA Comparison
Compare ABEO & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- LNZA
- Stock Information
- Founded
- ABEO N/A
- LNZA 2005
- Country
- ABEO United States
- LNZA United States
- Employees
- ABEO N/A
- LNZA N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- LNZA Major Chemicals
- Sector
- ABEO Health Care
- LNZA Industrials
- Exchange
- ABEO Nasdaq
- LNZA Nasdaq
- Market Cap
- ABEO 237.4M
- LNZA 199.8M
- IPO Year
- ABEO 1980
- LNZA N/A
- Fundamental
- Price
- ABEO $4.68
- LNZA $0.28
- Analyst Decision
- ABEO Strong Buy
- LNZA Hold
- Analyst Count
- ABEO 5
- LNZA 2
- Target Price
- ABEO $17.00
- LNZA $2.00
- AVG Volume (30 Days)
- ABEO 503.6K
- LNZA 4.4M
- Earning Date
- ABEO 03-20-2025
- LNZA 05-08-2025
- Dividend Yield
- ABEO N/A
- LNZA N/A
- EPS Growth
- ABEO N/A
- LNZA N/A
- EPS
- ABEO N/A
- LNZA N/A
- Revenue
- ABEO N/A
- LNZA $58,025,000.00
- Revenue This Year
- ABEO N/A
- LNZA N/A
- Revenue Next Year
- ABEO $561.86
- LNZA $77.26
- P/E Ratio
- ABEO N/A
- LNZA N/A
- Revenue Growth
- ABEO N/A
- LNZA 7.99
- 52 Week Low
- ABEO $3.05
- LNZA $0.20
- 52 Week High
- ABEO $8.45
- LNZA $3.41
- Technical
- Relative Strength Index (RSI)
- ABEO 36.32
- LNZA 30.80
- Support Level
- ABEO $4.42
- LNZA $0.22
- Resistance Level
- ABEO $5.14
- LNZA $0.35
- Average True Range (ATR)
- ABEO 0.25
- LNZA 0.07
- MACD
- ABEO -0.05
- LNZA -0.00
- Stochastic Oscillator
- ABEO 25.24
- LNZA 19.72
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.